Clinical trial results showed that participants experienced 15% to 18% weight loss during the trials
CAF-conditioned medium inhibited the accumulation of doxorubicin, but not taxol, in prostate cancer cells in a manner that was associated with increased cancer cell glutathione levels
Food and Drug administration approved semaglutide prescriptions to reduce the occurrences of cardiovascular disease for those with obesity
QUALIFIED RESEARCHERS ONLY: By purchasing, you represent and warrant that you are: A qualified researcher with appropriate scientific training and credentials Authorized to handle research chemicals in your jurisdiction Operating within a proper laboratory environment with appropriate safety protocols Purchasing for legitimate research purposes only Legal Compliance and Liability CUSTOMER RESPONSIBILITY: You are solely responsible for: Ensuring all purchases and uses comply with local, state, and federal laws in your jurisdiction Obtaining any required permits, licenses, or authorizations for possession and use Implementing appropriate safety protocols and protective measures Proper storage, handling, and disposal of all products Any consequences arising from possession, use, or misuse of our products INDEMNIFICATION: You agree to indemnify, defend, and hold harmless Hacker Peptides, its owners, employees, affiliates, suppliers, and agents from any and all claims, damages, losses, costs, liabilities, and expenses (including reasonable attorney fees) arising from or related to your purchase, possession, handling, use, misuse, or disposition of our products
